The changing patterns of antibiotics usage in Korea during 1981-2008

Infection and Chemotherapy

Volumn 44, Issue 6, 2012, Pages 411-418

  Kim, Youn Jeong ^a   Chun, Hyun Ji ^a   Lee, Jung Woo ^a   Hong, Kyung Wook ^a   Kim, Sang Il ^a   Wie, Seong Heon ^a   Kim, Yang Ree ^a   Kang, Moon Won ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

Anti bacterial agents; Cost; Daily defined dose; Korea; Production

Indexed keywords

AMINOGLYCOSIDE; AMINOPENICILLIN; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE INHIBITOR; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; CIPROFLOXACIN; LEVOFLOXACIN; LINCOSAMIDE; PENICILLIN DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE;

ANTIBIOTIC THERAPY; ARTICLE; COMBINATION CHEMOTHERAPY; DRUG COST; DRUG MANUFACTURE; DRUG USE; HEALTH INSURANCE; HUMAN; SOUTH KOREA;

EID: 84872871964     PISSN: 20932340     EISSN: 20926448     Source Type: Journal    
DOI: 10.3947/ic.2012.44.6.411     Document Type: Article

References (17)

1. rd ed. Seoul: MIP; 2008.
2. Song JH. Antimicrobial resistance in gram-positive cocci: past 50 years, present and future. Infect Chemother 2011;43:443-9.
3. Lee KW. Trend of bacterial resistance for the past 50 years in Korea and future perspectives - gram-negative bacteria. Infect Chemother 2011;43:458-67.
4. Göttig S, Pfeifer Y, Wichelhaus TA, Zacharowski K, Bingold T, Averhoff B, Brandt C, Kempf VA. Global spread of New Delhi metallo-β-lactamase 1. Lancet Infect Dis 2010;10:828-9.
5. Poirel L, Hombrouck-Alet C, Freneaux C, Bernabeu S, Nordmann P. Global spread of New Delhi metallo-β-lactamase 1. Lancet Infect Dis 2010;10:832.
6. Korea Pharmaceutical Manufacturers Association. Annual products of medicine. Seoul: KPMA; 2008.
7. Kang MW, Chung HY. Trends of antimicrobial drug usage in Korea. Korean J Infect Dis 1982;14:31-5.
8. Kang MW, Chung HY. Trends of antibiotic usage in Korea. Korean J Infect Dis 1989;21:257-63.
9. Kim YJ, Yoon CH, Baek KH, Kim YR, Yoo JH, Shin WS, Kang MW. The trend of antibiotics usage in Korea (II). Korean J Infect Dis 1995;13:43-55.
10. Kim SI, Park JM, Wie SH, Kim YR, Kang MW. The trend of antibiotics usage in Korea during 1981-1998. Korean J Infect Dis 2000;32:439-47.
11. Kim YJ, Lee SH, Kang YN, Kim WC, Kim SI, Wie SH, Kim YR, Kang MW. The trend of antibiotic production in Korea during 1981-2003. Korean J Infect Dis 2005;37:271-9.
12. WHO. WHO collaborating Center for Drug Statistics Methodology. Available at: http://www.whocc.no/atc_ddd_index/ Accessed 1 November 2011.
13. Lee K, Lee MA, Lee CH, Lee J, Roh KH, Kim S, Kim JJ, Koh E, Yong D, Chong Y; KONSAR Group. Increase of ceftazidime- and fluoroquinolone-resistant Klebsiella pneumoniae and imipenem-resistant Acinetobacter spp. in Korea: analysis of KONSAR study data from 2005 and 2007. Yonsei Med J 2010; 51:901-11.
14. KIMS. KIMSonline. Available at: http://www.kimsonline.co.kr/001_Detail/DrugDetailSearch.aspx?idx=aa. Accessed 1 July 2011.
15. Lee S, Lee K, Kang Y, Bae S. Prevalence of serotype and multidrugresistance of Streptococcus pneumoniae respiratory tract isolates in 265 adults and 36 children in Korea, 2002-2005. Microb Drug Resist 2010;16:135-42.
16. Kim SI, Kang MW. Current usage and prospect of new antifungal agents in Korea. Infect Chemother 2010;42:209-15.
17. Lee EK, Jang SM. Analysis of antibiotic consumption using the DDD(the defined daily dose) methodology and antibiotic expenditure. Kor J Clin Pharmacol Ther 2000;8:28-43.